Schedule 13G ownership disclosure
Aldeyra Therapeutics Inc
Security class unavailable · CUSIP: 01438T106
Event date: 2017-04-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 460,852
- Percent of class
- 3.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535264-17-000039
- Form type
- SC 13G
- Filer
- AWM Investment Company, Inc.
- CIK
- CIK 1535264
- Filed
- May 09, 2017
- Reporting period
- Apr 30, 2017
- Description
- Schedule 13G beneficial ownership